Tectonic Therapeutic TECX
NASDAQ TECX
$21.83 +0.68 (+3.19%)
At close: Oct 20, 2026 · 4:00 PM EDT

Tectonic Therapeutic (TECX) Preferred Stock Liabilities (2017 - 2025)

Updated

Tectonic Therapeutic (TECX) reported Preferred Stock Liabilities of $0.10 for Q4 2025.

Analysis

Tectonic Therapeutic (TECX) Preferred Stock Liabilities (2017 - 2025) Analysis & Trends

  • By year, Preferred Stock Liabilities came in at $80.63 million in FY2023.
  • The Q4 2025 figure ranks as the highest quarterly Preferred Stock Liabilities since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Tectonic Therapeutic 412.47 Mn -573.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.10
Dec 31, 2023 80.63 Mn
Dec 31, 2017 26.50 Mn
API Access

Tectonic Therapeutic Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=TECX&period=max&api_key=YOUR_API_KEY